FREE WEBINAR! Weds. August 12 at 1pm EDT REGISTER NOW ! Sponsored by: Solving Common Hematopathology Testing
Challenges with Next-Generation Sequencing
Try The Dark Report for 14 days, absolutely FREE Lab leaders rely on The Dark Report for actionable intelligence on key developments
in the laboratory testing industry, including compensation trends and market
milestones. It’s the single-best source of the information you need to maximize
the money you make, and the money you keep!
Start Your FREE Trial BONUS Special Report, Intelligence Assessment of Today’s
Clinical Laboratory Industry
, when you order today!
Free COVID-19 Webinar! Sponsored by Stream Now! Start and Scale COVID-19 Testing with Essential Tools that Support
the Business and Workflow of Your Lab
Held Weds., July 22
NEW WHITE PAPER! Translating Clinical Laboratory Science Into Business Objectives:
How an Educational Program Measured and Analyzed Performance
and Transformed the Approach to Improving Laboratory Operations
FREE DOWNLOAD! White Paper - Translating Clinical Lab Science into Business Objectives
Molecular Testing for Urinary Tract Infection (UTI):
2020 Update on Clinical Utility and Reimbursement Trends
3 High-Risk Medical Courier Support Services Risk Management
Specimen Management and Logistics Issues to Evaluate for Continuous
Quality Improvement

Latest White Papers

Molecular Testing for Urinary Tract Infection (UTI): 2020 Update on Clinical Utility and Reimbursement Trends

Molecular tests are becoming more routine as diagnostic tools, with many now covered by Medicare and commercial insurers. Advantages of molecular tests based on PCR technology include their ability to identify uropathogens traditionally missed by culture-based tests.

Driven by urgent, unmet analytical and clinical care needs, the adoption of the rapid molecular test—particularly RT-PCR for urinary tract infection control and treatment—has important implications.

read more
Case Studies in Clinical Laboratory Test Stewardship: The Financial and Clinical Impact of Clinical Decision Support in Hospital Laboratories

This white paper – the third in a three-part series developed in collaboration with Mayo Clinic Laboratories and Change Healthcare – provides frontline perspective and commentary from experts and physicians on the application and value of decision support in the laboratory. It also includes early-adopter proof points from hospital laboratories that have successfully implemented third-party decision support to achieve their stewardship goals, including EHR interventions and ongoing monitoring of utilization.

read more
Translating Clinical Laboratory Science Into Business Objectives: How an Educational Program Measured and Analyzed Performance and Transformed the Approach to Improving Laboratory Operations

Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and timely, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

read more
Critical Factors for Launching a Clinical Decision Support System in the Hospital Laboratory

This white paper—part 2 of a three-part series— provides practical pearls on how a proven decision support solution and one that is a good fit for your lab can be the foundation of an effective laboratory stewardship program, and can greatly assist in controlling utilization and meeting the challenges of value-based care. As well, the paper also clearly explains the points for “buy versus build” laboratory decision support.

Choosing the right decision support solution will empower your lab and hospital leaders, clinicians, and staff with more time to focus their core competencies on the provision of healthcare. Learn what you need to know by downloading this FREE whitepaper now.

read more
Anatomic Pathology at the Tipping Point? The Economic Case for Adopting Digital Technology and AI Applications Now

Driven by recent technological and regulatory approvals, leading academic and commercial laboratories are increasingly going digital to overcome significant gaps in efficiency and diagnostic accuracy. These same labs are implementing computational applications that leverage artificial intelligence (AI) to expand on the productivity, quality, and confidence gains they’ve already realized.

Download the White Paper now to get a synopsis of recent research and real-world cases that demonstrate the economic and scientific necessity of adopting digital pathology platforms and AI applications. Gather perspective from in-depth interviews with industry-leading labs that lay out the benefits they themselves gained from going digital.

read more

Latest E-Briefings

Abbott Lab’s ID NOW COVID-19 Rapid Molecular Test Continues to Face Scrutiny over ‘False Negatives’

Though the test initially drew ‘raves’ from Trump administration, the FDA now suggests negative results should be confirmed with an additional ‘high-sensitivity authorized SARS-CoV-2 molecular test’ This spring, as the United States attempted to jump-start a national...

read more

Coronavirus Fraud Takes Many Forms as Federal and Local Officials Continue to Pursue Widespread Cases of Clinical Laboratory Testing Scams

Since the pandemic began, federal investigators are specifically looking for patterns of fraud in Medicare claims data for COVID-19 clinical laboratory testing Last month, the federal Department of Health and Human Services (HHS) Office of Inspector General (OIG)...

read more

FEMA Paid a Just-Formed Company Millions of Dollars for COVID-19 Specimen Collection Tubes That Were Unusable for Clinical Laboratory Testing

The fledgling test-kit company sent plastic preforms that were intended for use in the manufacturing of soda bottles, not clinical laboratory specimen tubes When is a specimen tube not a specimen tube? When it is a plastic tube made for creating soda bottles. And that...

read more

New CMS Proposed Rule Encourages Value-Based Reimbursement Based on Patient Outcomes When Payers and Drug Manufacturers Negotiate Payment for Pricey Therapies

Clinical laboratories and anatomic pathology groups should consider this another example of how CMS is taking forward steps to encourage value-based payment arrangements throughout the health system With the sky-high cost of many prescription drugs and gene therapies,...

read more

Clinical Diagnostics Laboratory in Texas Charged $2,315 for One Coronavirus Test and Later Claims High Price Was a ‘Billing Error’

Media reporting on disparities in COVID-19 test billing sparks renewed calls for increased transparency in medical laboratory test charges Recent media reports of massive disparities in the prices charged for COVID-19 lab tests throughout the United States have...

read more

COVID-19 is Mutating and A Scripps Research Study Reveals the Coronavirus May Become Even More Infectious

Researchers found evidence indicating that the virus has—under selection pressure—made itself more stable, giving it a “significant boost in infectivity” While the COVID-19 pandemic continues to spread across the United States and throughout the world, new research...

read more

Banner Health Introduces Virtual Waiting Rooms in 300 Medical Clinics Across Its Nationwide Healthcare System

As digital healthcare continues to gain acceptance and regulatory support, clinical laboratories will need to help patients provide biological samples for virtual doctor visits Patterns are emerging in healthcare that will likely impact clinical laboratories now and...

read more

With Consumer Demand for Ancestry and Genealogy Genetic Tests Waning, Leading Genomics Companies are Investigating Ways to Commercialize the Aggregated Genetics Data They Have Collected

Genomics experts say this is a sign that clinical laboratory genetics testing is maturing into a powerful tool for population health Faced with lagging sales and employee layoffs, genomics companies in the genealogy DNA testing market are shifting their focus to the...

read more

Federal Prosecutors Charge a California Executive with Misleading Investors and Payers about Company’s Clinical Laboratory COVID-19 Test

Charges against this life science company executive include healthcare fraud as well as the first COVID-19 related securities fraud In the first securities fraud prosecution involving clinical laboratory COVID-19 testing, the US federal Department of Justice (DOJ)...

read more
Dark Daily

Latest Webinars

shah MD FEATURED SPEAKERS Parth Shah, MD Fellow, Hematology & Oncology
Dartmouth-Hitchcock Lebanon, NH
Dr Sait FEATURED SPEAKERS Sheila Sait, PhD Assistant Director & Research
Coordinator Clinical Cytogenetics
Laboratory Roswell Park Comprehensive
Cancer Center
Buffalo, NY
Sheila Sait, PhD Assistant Director & Research Coordinator Clinical Cytogenetics Laboratory Roswell Park Comprehensive Cancer Center Buffalo, NY
wesgard Sr. FEATURED SPEAKERS James O. Westgard, PhD Founder, Principal Madison, WI James O. Westgard, PhD, FACB Westgard QC, Inc.